Barington Capital Group L.P. Has $15.52 Million Stock Holdings in TriMas Co. (NASDAQ:TRS)

Barington Capital Group L.P. grew its holdings in TriMas Co. (NASDAQ:TRS) by 4.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 608,000 shares of the industrial products company’s stock after purchasing an additional 25,000 shares during the quarter. TriMas makes up approximately 16.4% of Barington Capital Group L.P.’s holdings, making the stock its 2nd biggest holding. Barington Capital Group L.P. owned about 1.50% of TriMas worth $15,522,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of TRS. Innealta Capital LLC acquired a new stake in shares of TriMas during the second quarter worth $26,000. Aristides Capital LLC bought a new position in TriMas during the second quarter worth about $245,000. Intech Investment Management LLC acquired a new position in shares of TriMas during the 3rd quarter worth about $269,000. Paloma Partners Management Co bought a new stake in shares of TriMas in the 3rd quarter valued at about $293,000. Finally, Algert Global LLC raised its position in shares of TriMas by 4.2% in the 2nd quarter. Algert Global LLC now owns 15,779 shares of the industrial products company’s stock valued at $403,000 after acquiring an additional 639 shares during the period. Institutional investors and hedge funds own 99.42% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on TRS. StockNews.com upgraded shares of TriMas from a “sell” rating to a “hold” rating in a report on Wednesday, November 13th. BWS Financial reissued a “buy” rating and issued a $40.00 price target on shares of TriMas in a report on Tuesday, November 5th.

TriMas Trading Up 0.2 %

NASDAQ:TRS opened at $26.42 on Monday. The business’s 50-day simple moving average is $26.42 and its 200-day simple moving average is $25.84. TriMas Co. has a fifty-two week low of $22.45 and a fifty-two week high of $28.51. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44. The stock has a market capitalization of $1.07 billion, a PE ratio of 41.28 and a beta of 0.66.

TriMas (NASDAQ:TRS) last announced its quarterly earnings results on Monday, November 4th. The industrial products company reported $0.43 earnings per share for the quarter, missing analysts’ consensus estimates of $0.57 by ($0.14). TriMas had a net margin of 2.93% and a return on equity of 9.21%. The company had revenue of $229.36 million during the quarter, compared to the consensus estimate of $239.33 million. During the same period in the previous year, the firm posted $0.57 EPS. The business’s quarterly revenue was down 2.5% compared to the same quarter last year. Sell-side analysts expect that TriMas Co. will post 1.69 earnings per share for the current fiscal year.

TriMas Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, November 12th. Shareholders of record on Tuesday, November 5th were issued a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a yield of 0.61%. The ex-dividend date of this dividend was Tuesday, November 5th. TriMas’s dividend payout ratio (DPR) is presently 25.00%.

TriMas Company Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.